PYXS
Pyxis Oncology·NASDAQ
--
--(--)
--
--(--)
6.83 / 10
Outperform
Analyst coverage is overwhelmingly bullish: two Strong Buy ratings, one with 75% historical win rate. Sentiment scores 6.8/10 and fund‑flow rating is good (7.6/10) with positive inflows across all size blocks. This supports a favorable outlook despite price decline.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-24
InstitutionStifel
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for PYXS?
- PYXS holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.83/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
